Peter Sellei
Analyst-Equity bij Erik Penser Bank AB
Profiel
Peter Sellei currently works at Erik Penser Bank AB, as Analyst from 2021.
Dr. Sellei also formerly worked at Biovitrum AB, as Director, Swedish Orphan Biovitrum AB, as Director from 2009 to 2010, and Carnegie Investment Bank AB, as Analyst in 2003.
Actieve functies van Peter Sellei
| Bedrijven | Functie | Begin |
|---|---|---|
Erik Penser Bank AB
 Erik Penser Bank AB Investment Banks/BrokersFinance Part of Erik Penser AB, Erik Penser Bank AB is a brokerage services provider. The private company is based in Stockholm, Sweden. The Swedish company was founded in 1965. Johan Mörner has been the CEO of the company since 2014. | Analyst-Equity | 01-03-2021 |
Eerdere bekende functies van Peter Sellei
| Bedrijven | Functie | Einde |
|---|---|---|
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Director/Board Member | 27-04-2010 |
| SWEDISH ORPHAN BIOVITRUM AB | Director/Board Member | 26-04-2010 |
Carnegie Investment Bank AB
 Carnegie Investment Bank AB Investment Banks/BrokersFinance Carnegie Investment Bank AB is the broker/delear subsidiary of Carnegie Holding AB in Sweden. Headquartered in Stockholm, the firm was founded in 1803 and offers institutional clients several services within research, equity sales and equity capital market transactions (ECM). The Fixed Income unit offers bond research and sales. Carnegie Investment Bank’s research and equity sales enjoy a global position in Nordic equities. | Analyst-Equity | 23-04-2003 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Carnegie Investment Bank AB
Carnegie Investment Bank AB Investment Banks/BrokersFinance Carnegie Investment Bank AB is the broker/delear subsidiary of Carnegie Holding AB in Sweden. Headquartered in Stockholm, the firm was founded in 1803 and offers institutional clients several services within research, equity sales and equity capital market transactions (ECM). The Fixed Income unit offers bond research and sales. Carnegie Investment Bank’s research and equity sales enjoy a global position in Nordic equities. | Finance |
Erik Penser Bank AB
Erik Penser Bank AB Investment Banks/BrokersFinance Part of Erik Penser AB, Erik Penser Bank AB is a brokerage services provider. The private company is based in Stockholm, Sweden. The Swedish company was founded in 1965. Johan Mörner has been the CEO of the company since 2014. | Finance |
